Systematic evaluation of narrow-sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort.
Clin Genet
; 103(6): 636-643, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-36840471
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostate
/
Prostatic Neoplasms
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
/
Male
Language:
En
Journal:
Clin Genet
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Denmark